The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients

Table 1 Chemotherapy treatment and drug classes

Drug	Category	Frequency	Dose	Cancer type
*Standard administration*
Epirubicin	Anthracycline	2 W	100 mg/m²	Breast
Paclitaxel	Taxane	3 W	175 mg/m²	Breast
Carboplatin	Alkylating agent	3 W	AUC6	Lung, ovarian
*Metronomic administration*
Vinorelbine	Vinca alkaloid	5D	30 mg	Breast, lung, prostate
Capecitabine	Anti-metabolite	14Q21	2000 mg	Colorectal
Temozolomide	Alkylating agent	OD	100 mg	Colorectal

2 W: every 2 weeks, 3 W: every 3 weeks, 5D: every 5 days, 14Q21: 14 days every 21 days, OD: once daily (the cycle of chemotherapy treatment was 3 weeks), AUC: area under the curve.

ISSN: 2162-3619